## Abstract Bone marrow blast cell antigen expression from 86 patients with __de novo__ acute myeloid leukemias (AML) was studied and correlated with FAB classification and clinical outcome. Among a panel of 14 monoclonal antibodies routinely used for the diagnosis of acute leukemias we studied the
Role of blast cell immunophenotyping for the diagnosis and prognosis of acute myeloid leukemia
โ Scribed by Dubose-Marchenay, Nadine; Lacombe, Francis; Dumain, Patrice; Belloc, Francis; Boisseau, Michel R.; Reiffers, Josy
- Book ID
- 122310242
- Publisher
- Portland Press
- Year
- 1992
- Tongue
- English
- Weight
- 141 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0248-4900
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract The immunophenotype of peripheral blood blast cells was tested in 92 patients with acute myeloid leukemia (AML), who were diagnosed and treated at single centre, St Bartholomew's Hospital, from 1978โ1987 with a standard adriamycin, cytosine arabinoside and 6โthioguanine regimen. Immunol
## Acute promyelocytic leukemia (APL), defined by the French-American-British (FAB) classification as the M3 subtype of acute myeloblastic leukemia (AML), is readily diagnosed by direct cytomorphologic examination. The potential difficulty in recognizing the microgranular variant of APL (M3v) stems